November 22, 2014 3:58 AM ET


Company Overview of ViroPharma Inc.

Executive Profile

Vincent J. Milano

Director, Chairman of Compensation Committee and Member of Audit Committee, Vanda Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 4 different industries.

See Board Relationships


Mr. Vincent J. Milano, also known as Vinnie, served as the Chief Executive Officer and President of ViroPharma Inc. from March 31, 2008 to January 24, 2014. Mr. Milano served as the Chief Operating Officer of ViroPharma Inc., from January 2006 to March 2008, Vice President from November 1997 to March 2008, Chief Financial Officer from November 1997 to October 2008, Treasurer from July 1996 to 2006 and Principal Accounting Officer until April 2008. Mr. Milano served as ...

Corporate Headquarters

730 Stockton Drive
Exton, Pennsylvania 19341

United States

Phone: 610-458-7300
Fax: 610-458-7380

Board Members Memberships

Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Former Chairman, Chief Executive Officer and President
Director, Chairman of Compensation Committee and Member of Audit Committee
Member of The Board of Directors


Rider University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$84,582
Unexercisable Options$10,418
Total Number of Options$95,000

Total Compensation

Total Annual Cash Compensation$51,250
Total Calculated Compensation$123,400

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Masayo Tada Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee
Sumitomo Dainippon Pharma Co., Ltd.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ViroPharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at